Incyte Corp

A breakout could be in the cards for this biopharmaceutical play, says Carter Worth

(Check out Carter's worthcharting.com for actionable recommendations and live nightly videos.) Sideways since November, biopharmaceutical company Incyte is now moving out of the seven-month range in which it's been mired.…